Crinetics Pharmaceuticals Financial Overview
Crinetics Pharmaceuticals's market cap is currently $4.79B. The company's EPS TTM is $-1.38; its P/E ratio is ―; Crinetics Pharmaceuticals is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-1.34. See an overview of income statement, balance sheet, and cash flow financials.
